V CompBrief BY VELARION

Chief Operating Officer · Design Therapeutics, Inc. (DSGN)

Sean Jeffries

Sean Jeffries, Chief Operating Officer of Design Therapeutics, Inc., received total compensation of $1,891,530 for fiscal year 2025. This amount included a base salary of $484,000, a cash bonus of $200,000, and stock-based compensation of $1,193,530.

FY2025 is the first fiscal year CompBrief holds for Sean Jeffries as a named executive officer of Design Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,891,530

Compensation figures as of the proxy filed April 23, 2026 (DEF 14A).

Sean Jeffries compensation by year

Design Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Design Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$484,000
Bonus$6,400
Stock awards$0
Option awards$1,193,530
Non-equity incentive$193,600
Pension and deferred compensation$0
All other$14,000
Total$1,891,530

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Design Therapeutics, Inc. DEF 14A filed April 23, 2026, accession 0001193125-26-173678, and prior-year filings. Open the filing on EDGAR.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option17,500—$12.77
Option215,834—$2.54
Option260,000—$6.17
Option49,000—$7.97

Per the Outstanding Equity Awards at Fiscal Year-End table in Design Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Design Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Pratik ShahPresident, Chief Executive Officer and Chairperson$3,544,300
Chris StorgardChief Medical Officer$2,030,270
Sean Jeffries · this pageChief Operating Officer$1,891,530

The full Design Therapeutics compensation record

free company brief
Design Therapeutics, Inc. (DSGN) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within Design Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Design Therapeutics's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $1,500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Design Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy